Skip to content
Products & Services · Net revenues

Elahere — Net revenues

AbbVie Elahere — Net revenues increased by 8.8% to $198M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.6%, from $179M to $198M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2022
Last reportedQ1 2026May 8, 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates successful market adoption and growing demand for the therapy, while a decrease may signal increased competition or loss of market share.

Detailed definition

This metric represents the total gross sales of the Elahere product line minus returns, allowances, and rebates. It serv...

Peer comparison

Comparable to revenue metrics for specific oncology assets or specialty pharmaceutical products at peer biopharmaceutical companies.

Metric ID: abbv_segment_elahere_net_revenues

Historical Data

17 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0$0$0$0$0$0$0$0$64M$128M$139M$148M$179M$159M$170M$182M$198M
QoQ Change+100.0%+8.6%+6.5%+20.9%-11.2%+6.9%+7.1%+8.8%
YoY Change+179.7%+24.2%+22.3%+23.0%+10.6%
Range$0$198M
Avg YoY Growth+52.0%
Median YoY Growth+23.0%
Current Streak3 quarters growth

Frequently Asked Questions

What is AbbVie's elahere — net revenues?
AbbVie (ABBV) reported elahere — net revenues of $198M in Q1 2026.
How has AbbVie's elahere — net revenues changed year-over-year?
AbbVie's elahere — net revenues increased by 10.6% year-over-year, from $179M to $198M.
What does elahere — net revenues mean?
The total net sales generated by the Elahere pharmaceutical product.